Literature DB >> 11069327

Safety of proton pump inhibitors.

H L Waldum, E Brenna, T C Martinsen.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11069327     DOI： 10.1046/j.1365-2036.2000.00859.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  5 in total

1.  Hypergastrinaemia in patients infected with Helicobacter pylori treated with proton pump inhibitors.

Authors:  H L Waldum
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 2.  Animal models to study the role of long-term hypergastrinemia in gastric carcinogenesis.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Tom Chr Martinsen; Øyvind Hauso; Helge L Waldum
Journal:  J Biomed Biotechnol       Date:  2010-11-24

Review 3.  Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Authors:  Reidar Fossmark; Gunnar Qvigstad; Helge-L Waldum
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

4.  Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: an experimental in vivo study.

Authors:  Luigi Dall'Olmo; Matteo Fassan; Elisa Dassie; Marco Scarpa; Stefano Realdon; Francesco Cavallin; Matteo Cagol; Giorgio Battaglia; Marco Pizzi; Vincenza Guzzardo; Erica Franceschinis; Gianfranco Pasut; Massimo Rugge; Giovanni Zaninotto; Nicola Realdon; Carlo Castoro
Journal:  PLoS One       Date:  2014-11-21       Impact factor: 3.240

Review 5.  Adverse Effects of Proton Pump Inhibitors-Evidence and Plausibility.

Authors:  Reidar Fossmark; Tom C Martinsen; Helge L Waldum
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.